BioCentury
ARTICLE | Company News

Potenza Therapeutics, Astellas deal

April 27, 2015 7:00 AM UTC

Astellas partnered with Potenza to discover and develop immuno-oncology candidates targeting undisclosed immune checkpoint pathways, co-stimulatory signals and regulatory T cells. Astellas also gained...